PUS7 Deficiency: Phenotypical Expansion of PUS7-Related Neurodevelopmental Disorders
Alice Muda1, Barbara Belmessieri1, Patrizia Accorsi2
1Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Abstract:
Pathogenic variants in PUS7, encoding pseudouridine synthase 7, cause a rare neurodevelopmental disorder marked by intellectual disability, microcephaly, short stature, and behavioral disturbances. Since the first report in 2018, only 16 patients have been described. We report a novel case with a homozygous pathogenic PUS7 variant and present an updated review of all cases published between 2018 and 2025. Across 17 cases, the most frequent features were moderate/severe intellectual disability, delayed/absent speech, aggressive behavior, microcephaly, mild facial dysmorphisms, motor delay, and short stature. These features are common but non-specific, with the exception of aggressiveness that manifests at a very early age. Less common but more peculiar findings included sensorineural hearing loss, autistic traits, self-injurious behavior, and motor stereotypies. The combination of core features with these more specific symptoms should prompt suspicion of a PUS7-related disorder. We recommend looking for PUS7 pathological variants when performing whole exome sequencing in children with this constellation of neurodevelopmental and behavioral signs.
Related Concept Videos
Pleiotropy
Parkinson Disease ll: Pathophysiology
Inborn Errors of Metabolism
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

